Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Immunovant Inc

Current price
26.19 USD -0.61 USD (-2.28%)
Last closed 26.8 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 3 825 154 304 USD
Yield for 12 month +31.74 %
21.11.2021 - 28.11.2021

Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. The company develops batoclimab, a novel fully human monoclonal antibody that target the neonatal fragment crystallizable receptor for the treatment of myasthenia gravis, thyroid eye disease, chronic inflammatory demyelinating polyneuropathy, Graves diseases, and warm autoimmune hemolytic anemia. Immunovant, Inc. is based in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd. Address: 320 West 37th Street, New York, NY, United States, 10018

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
MSFT MSFT Microsoft


WallStreet Target Price

49.85 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-231 000 USD

Last Year

-1 324 000 USD

Current Quarter

-64 000 USD

Last Quarter

-58 000 USD

Key Figures IMVT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -269 977 984 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -31.5 %
PEG Ratio
Return On Equity TTM -52.91 %
Wall Street Target Price 49.85 USD
Revenue TTM
Book Value 4.24 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -1.88 USD
Diluted Eps TTM -1.88 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics IMVT

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History IMVT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation IMVT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -14.1221
Price Book MRQ 6.2836

Financials IMVT

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators IMVT

For 52 weeks

18.16 USD 45.58 USD
50 Day MA 28.36 USD
Shares Short Prior Month 9 286 588
200 Day MA 33.29 USD
Short Ratio 9.09
Shares Short 9 205 378
Short Percent 13.23 %

Dynamics of changes in the value of assets




446.34 USD Microsoft Corporation -3.37 (-0.75%)
Detailed analytics

ETF funds



203.95 CHF UBS SLI A-dis -0.06 (-0.02%)
Detailed analytics



2339.94 USD Gold +11.09 (+0.48%)
Detailed analytics